Jurgens Chris W D, Rau Katie E, Knudson Chris A, King Jacob D, Carr Patrick A, Porter James E, Doze Van A
Department of Pharmacology, Physiology and Therapeutics, School of Medicine and Health Sciences, University of North Dakota, 501 North Columbia Rd., Grand Forks, ND 58202-9037, USA.
J Pharmacol Exp Ther. 2005 Aug;314(2):552-60. doi: 10.1124/jpet.105.085332. Epub 2005 May 20.
Norepinephrine is an endogenous neurotransmitter distributed throughout the mammalian brain. In higher cortical structures such as the hippocampus, norepinephrine, via beta adrenergic receptor (AR) activation, has been shown to reinforce the cognitive processes of attention and memory. In this study, we investigated the effect of beta1AR activation on hippocampal cornu ammonis 3 (CA3) network activity. AR expression was first determined using immunocytochemistry with antibodies against beta1ARs, which were found to be exceptionally dense in hippocampal CA3 pyramidal neurons. CA3 network activity was then examined in vitro using field potential recordings in rat brain slices. The selective betaAR agonist isoproterenol caused an enhancement of hippocampal CA3 network activity, as measured by an increase in frequency of spontaneous burst discharges recorded in the CA3 region. In the presence of alphaAR blockade, concentration-response curves for isoproterenol, norepinephrine, and epinephrine suggested that a beta1AR was involved in this response, and the rank order of potency was isoproterenol > norepinephrine = epinephrine. Finally, equilibrium dissociation constants (pK(b)) of subtype-selective betaAR antagonists were functionally determined to characterize the AR subtype modulating hippocampal CA3 activity. The selective beta1AR antagonists atenolol and metoprolol blocked isoproterenol-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively. In contrast, the selective beta2AR antagonists ICI-118,551 and butoxamine inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively). Together, this pharmacological profile of subtype-selective betaAR antagonists indicates that in this model, beta1AR activation is responsible for the enhanced hippocampal CA3 network activity initiated by isoproterenol.
去甲肾上腺素是一种内源性神经递质,分布于整个哺乳动物大脑。在诸如海马体等高级皮质结构中,已表明去甲肾上腺素通过β肾上腺素能受体(AR)激活来加强注意力和记忆的认知过程。在本研究中,我们调查了β1AR激活对海马体海马角3(CA3)网络活动的影响。首先使用针对β1ARs的抗体通过免疫细胞化学确定AR表达,发现其在海马CA3锥体神经元中异常密集。然后在体外使用大鼠脑片的场电位记录来检查CA3网络活动。选择性βAR激动剂异丙肾上腺素导致海马CA3网络活动增强,这通过CA3区域记录的自发爆发放电频率增加来衡量。在存在αAR阻断的情况下,异丙肾上腺素、去甲肾上腺素和肾上腺素的浓度 - 反应曲线表明β1AR参与了该反应,效力顺序为异丙肾上腺素>去甲肾上腺素 = 肾上腺素。最后,功能测定亚型选择性βAR拮抗剂的平衡解离常数(pK(b))以表征调节海马CA3活动的AR亚型。选择性β1AR拮抗剂阿替洛尔和美托洛尔阻断了异丙肾上腺素诱导的增强作用,表观K(b)值分别为85±36和3.9±1.7 nM。相比之下,选择性β2AR拮抗剂ICI - 118,551和布托胺以明显低亲和力(分别为222±61和9268±512 nM的K(b))抑制异丙肾上腺素介导的增强作用。总之,亚型选择性βAR拮抗剂的这种药理学特征表明,在该模型中,β1AR激活负责异丙肾上腺素引发的海马CA3网络活动增强。